| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/06/2013 | EP2552924A1 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs |
| 02/06/2013 | EP2552921A1 Purine compounds |
| 02/06/2013 | EP2552920A1 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 02/06/2013 | EP2552918A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors |
| 02/06/2013 | EP2552916A1 Purine compounds used as cb2 agonists |
| 02/06/2013 | EP2552909A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| 02/06/2013 | EP2552489A1 Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant |
| 02/06/2013 | EP2552486A1 Transdermal delivery patch |
| 02/06/2013 | EP2552473A2 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain |
| 02/06/2013 | EP2552458A1 Injectable dendrimer hydrogel nanoparticles |
| 02/06/2013 | EP2552446A1 Method for treating schizophrenia and related diseases |
| 02/06/2013 | EP2552433A2 Compositions and methods for the treatment of somatosensory disorders |
| 02/06/2013 | EP2552430A1 Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy |
| 02/06/2013 | EP2552425A1 Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists |
| 02/06/2013 | EP2552200A1 Dimethyl sulfoxide (dmso) formulations for treating autism |
| 02/06/2013 | CN1993327B 3-Carbamoyl-2-pyridone derivative |
| 02/06/2013 | CN102918036A 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace) |
| 02/06/2013 | CN102918034A Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/06/2013 | CN102918031A Radiolabeled compounds and methods thereof |
| 02/06/2013 | CN102918021A Nicotinic receptor non-competitive antagonists |
| 02/06/2013 | CN102917723A Soybean protein hydrolysate-containing antioxidant and use thereof |
| 02/06/2013 | CN102917703A Novel EP4 agonist |
| 02/06/2013 | CN102917701A Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 02/06/2013 | CN102917700A Neurodegenerative disease therapeutic agent |
| 02/06/2013 | CN102911879A Chaetomium globosum and application thereof |
| 02/06/2013 | CN102911843A Preparation method of eclipta alba hair-blacking wine |
| 02/06/2013 | CN102911222A Extraction method of aucubin and application of aucubin |
| 02/06/2013 | CN102911188A Sulfur-containing diindolyl diketopiperazine compounds and application thereof in preparing antineoplastic drugs |
| 02/06/2013 | CN102911163A Quinazoline derivatives, composition containing derivatives and pharmaceutical application of derivatives |
| 02/06/2013 | CN102911075A New crystal form I of agomelatine sulfate and preparation method thereof |
| 02/06/2013 | CN102911040A Sesquiterpenoids from marine fungi source as well as preparation method and application thereof |
| 02/06/2013 | CN102908707A Hui medicine oxygen mask and matched medical oxygen medicated pad as well as preparation method of medicated pad |
| 02/06/2013 | CN102908604A Bighead atractylodes rhizome and gastrodia tuer capsules |
| 02/06/2013 | CN102908594A Anti-influenza and anti-common-cold Chinese herbal compound prescription and preparation method and application thereof |
| 02/06/2013 | CN102908587A Brain-building intelligence-reinforcing pill for treating brain exhaustion psychosis |
| 02/06/2013 | CN102908585A Traditional Chinese medicine for treating ischioneuralgia |
| 02/06/2013 | CN102908572A Application of Ruyizhenbao pill/tablet to treatment of vascular dementia |
| 02/06/2013 | CN102908570A Traditional Chinese medicine for treating cerebral atrophy |
| 02/06/2013 | CN102908542A Prescription for insomnia |
| 02/06/2013 | CN102908541A Traditional Chinese medicine for treating prosopalgia |
| 02/06/2013 | CN102908537A Preparation method for medication--epilepsy pill for the treatment of epilepsy |
| 02/06/2013 | CN102908533A Preparation method for pine leaf and notopterygium root wine |
| 02/06/2013 | CN102908521A Traditional Chinese medicine for treating hemicrania by using fruit of tibet lancea |
| 02/06/2013 | CN102908506A Preparation method of tranquilizer pills mainly containing cinnabar root poria for treating palpitation and insomnia |
| 02/06/2013 | CN102908503A Traditional Chinese medicine pill for treating insomnia |
| 02/06/2013 | CN102908502A Traditional Chinese medicine for soothing nerves |
| 02/06/2013 | CN102908496A Traditional Chinese medicine composition for treating Parkinson's disease and application of traditional Chinese medicine composition |
| 02/06/2013 | CN102908486A Preparation method of thinleaf milkwort root and acorus gramineus pills used for treating amnesia |
| 02/06/2013 | CN102908474A Medicinal liquor for treating neurosis |
| 02/06/2013 | CN102908473A Traditional Chinese medicine preparation for treating trigeminal neuralgia by utilizing kadsura heteroclita |
| 02/06/2013 | CN102908472A Method of preparing medication angelica and cocklebur powder for treatment of headache |
| 02/06/2013 | CN102908462A Isatis root particle and preparation method thereof |
| 02/06/2013 | CN102908460A Oolong tea throat lozenge and preparation method thereof |
| 02/06/2013 | CN102908453A Double-tonifying pills |
| 02/06/2013 | CN102908441A Pain relieving micro-emulsion pharmaceutical composition gel ointment and preparation method thereof |
| 02/06/2013 | CN102908435A Temperance capsule |
| 02/06/2013 | CN102908421A Chinese medicinal prescription for stag and preparation method thereof |
| 02/06/2013 | CN102908401A Application of fructus piperis longi on preparation of medicine for inhibiting neuroinflammation |
| 02/06/2013 | CN102908396A Chinese medicinal composition for promoting sleeping and preparation method thereof |
| 02/06/2013 | CN102908390A Preparation method of Fructus Schisandrae/indigo honeysuckle oral liquid containing crude polysaccharides |
| 02/06/2013 | CN102908363A Deproteinized calf blood extract and preparation process thereof |
| 02/06/2013 | CN102908360A Glycerin fructose sodium chloride injection and preparation process thereof |
| 02/06/2013 | CN102908339A Tapentadol compositions |
| 02/06/2013 | CN102908336A Stable preparation of phosphatidylserine and preparation method, application as well as application product of stable preparation |
| 02/06/2013 | CN102908331A Duloxetine hydrochloride enteric capsules and preparation method thereof |
| 02/06/2013 | CN102908329A Divalproex sodium enteric-coated tablet and preparation method thereof |
| 02/06/2013 | CN102233071B Traditional Chinese medicine composition for treating depression and preparation method thereof |
| 02/06/2013 | CN102225105B Medicine for treating migraine |
| 02/06/2013 | CN102160890B Pharmaceutical composition comprising an analgesic peptide |
| 02/06/2013 | CN101925576B Kappa selective opioid receptor antagonist |
| 02/06/2013 | CN101809018B Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate and using method thereof |
| 02/06/2013 | CN101797273B Method for extracting total flavonoid glycoside from ginkgo leaves |
| 02/06/2013 | CN101778628B Methods for treating anxiety |
| 02/06/2013 | CN101675046B Therapeutic agents |
| 02/05/2013 | US8367700 Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators |
| 02/05/2013 | US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
| 02/05/2013 | US8367657 Processes for preparing 3-benzazepines |
| 02/05/2013 | US8367656 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,S-dioxide used to treat depressive disorders, irritable bowel syndrome, attention deficit hyperactivity disorder, asthma |
| 02/05/2013 | US8367655 Pyridoindolobenzox—and thiazepine derivatives and uses thereof |
| 02/05/2013 | US8367605 Copolymer-1 improvements in compositions of copolymers |
| 02/05/2013 | US8367118 Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/05/2013 | CA2703157C Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
| 02/05/2013 | CA2684404C Novel piperazine salts as d3/d2 antagonists |
| 02/05/2013 | CA2672190C 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands |
| 02/05/2013 | CA2600478C Imidazopyridazine compounds |
| 02/05/2013 | CA2591033C Heterocyclic aspartyl protease inhibitors |
| 02/05/2013 | CA2558899C Fused ring azadecalin glucocorticoid receptor modulators |
| 02/05/2013 | CA2557766C Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 02/05/2013 | CA2555099C Alcohol metabolism moderating composition |
| 02/05/2013 | CA2515975C Peptide derivatives having .beta.-secretase inhibitory activity |
| 02/05/2013 | CA2511340C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/05/2013 | CA2492273C 3, 10, and 12a substituted tetracycline compounds |
| 02/05/2013 | CA2479555C Use of cocoa flavanols and oligomers thereof to treat cognitive dysfunction and improve cognitive function in neuro-compromised patients |
| 02/05/2013 | CA2454337C Pharmaceutical compositions for the treatment of movement disorders |
| 02/05/2013 | CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 01/31/2013 | WO2013016727A1 Cysteine prodrugs |
| 01/31/2013 | WO2013016332A2 Composition and method for treating migraines |
| 01/31/2013 | WO2013016193A2 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 01/31/2013 | WO2013016178A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | WO2013016073A1 Alpha-2 adrenergic modulators for treating visual disorders mediated by central visual projections from the eye |